Last updated: December 20, 2025
Content Philosophy
All content on Weight Loss Provider Guide is created to inform, not to persuade. We prioritize accuracy and helpfulness over engagement metrics. Our goal is to help readers make informed decisions about GLP-1 medications, not to drive them toward any particular provider or treatment.
Editorial Oversight
Reviewed by: WPG Research Team
All content is reviewed by our editorial team before publication. We verify facts, check sources, and ensure claims are accurate and appropriately qualified. Our team researches GLP-1 telehealth programs and summarizes clinical evidence using primary sources.
Informational Content Only
Nothing on this website constitutes medical advice. Our content is educational and intended to help readers understand their options. We always encourage readers to consult with a qualified healthcare provider before making any decisions about medications or treatments.
What We Will Not Do
- Promise or guarantee weight loss results to readers
- Use before-and-after photos or testimonials
- Create artificial urgency or scarcity
- Publish content that contradicts established medical guidance
- Recommend providers that do not meet our verification standards
- Allow advertisers to influence our rankings or editorial coverage
If a provider advertises a guarantee, we describe it as a provider policy (with terms)—not as a promise of typical results.
How We Research
Our research process includes:
- Direct verification of provider claims through their websites and support channels
- Confirmation of pharmacy licensing and accreditation
- Review of publicly available feedback and regulatory actions as context (we do not treat unverified star ratings as primary evidence)
- Regular re-verification of pricing and policies
Sources and Citations
We prioritize primary and authoritative sources, including:
- FDA prescribing information, safety communications, and drug databases
- Peer-reviewed clinical trials and systematic reviews (e.g., PubMed-indexed journals)
- Official provider websites, terms of service, pricing pages, and written policies
- Public licensing and regulatory information for pharmacies and (when available) clinicians
When we state a medical statistic or describe clinical evidence, we cite a primary source whenever possible. When we describe provider pricing or policies, we cite or link to the provider's official materials whenever possible.
Compounded Medication Disclosure
When we cover providers offering compounded semaglutide or tirzepatide, we note that compounded medications are not FDA-approved products. While 503A and 503B compounding pharmacies are regulated facilities, the specific compounded drug formulations have not been reviewed by the FDA for safety and efficacy. We include this disclosure wherever compounded options are discussed to ensure readers can make fully informed decisions.
Clinical Review (When Used)
Some pages that focus primarily on medication safety may be reviewed by a licensed clinician (e.g., PharmD/RD/NP/MD). When that happens, the reviewer's name and credentials will be shown on the page. This review does not replace care from your personal clinician.
Corrections Policy
Accuracy matters. If you believe something on our site is inaccurate or outdated, email [email protected] and include:
- The page URL
- What you believe is incorrect
- A supporting source link or screenshot (if available)
If we verify an error, we update the page promptly and revise the "Last updated" date where applicable.
Update Frequency
Provider pricing and policies can change frequently. We aim to verify core comparison tables regularly and update content whenever we identify material changes. Each comparison page displays its last verification date.